OAM
IMMU

Oxford Asset Management’s Immunomedics Inc IMMU Stock Holding History

Oxford Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,078
Closed -$209K – 2239
2018
Q3 		$209K Buy
+10,078
New +$239K ﹤0.01% 1594
2015
Q1 		– Sell
-206,813
Closed -$1M – 788
2014
Q4 		$1M Buy
+206,813
New +$818K 0.02% 473
2013
Q3 		– Sell
-251,955
Closed -$1.37M – 954
2013
Q2 		$1.37M Buy
+251,955
New +$828K 0.04% 533

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Oxford Asset Management's IMMU Position: Q4 2018 in Review

Oxford Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 10,078 shares — an estimated $209K sold.

Oxford Asset Management first reported a position in IMMU in Q2 2013 and held it in 3 quarters. The position peaked at $1.37M in Q2 2013. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • Oxford Asset Management reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • Oxford Asset Management sold 10,078 Immunomedics Inc shares in Q4 2018, an estimated $209K.
  • Oxford Asset Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 3 quarters.
  • Oxford Asset Management's Immunomedics Inc position peaked at $1.37M in Q2 2013.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.